| Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study The Lancet Infectious Diseases 16 (5), 565-575, 2016 | 249 | 2016 |
| HIV-1 genetic variability and clinical implications MM Santoro, CF Perno International Scholarly Research Notices 2013, 2013 | 189 | 2013 |
| Comet assay and micronucleus test in circulating erythrocytes of Cyprinus carpio specimens exposed in situ to lake waters treated with disinfectants for potabilization A Buschini, A Martino, B Gustavino, M Monfrinotti, P Poli, C Rossi, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 557 (2 …, 2004 | 171 | 2004 |
| Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. HG Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M ... Curr HIV Res 9 (6), 446-69, 2011 | 107 | 2011 |
| Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors V Svicher, T Sing, MM Santoro, F Forbici, F Rodríguez-Barrios, A Bertoli, ... Journal of virology 80 (14), 7186-7198, 2006 | 98 | 2006 |
| Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to … F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ... Journal of virology 81 (20), 11507-11519, 2007 | 83 | 2007 |
| Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors V Svicher, F Ceccherini-Silberstein, F Erba, M Santoro, C Gori, ... Antimicrobial agents and chemotherapy 49 (5), 2015-2025, 2005 | 77 | 2005 |
| Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels MM Santoro, L Fabeni, D Armenia, C Alteri, D Di Pinto, F Forbici, A Bertoli, ... Clinical infectious diseases 58 (8), 1156-1164, 2014 | 74 | 2014 |
| Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses A Artese, V Svicher, G Costa, R Salpini, VC Di Maio, M Alkhatib, ... Drug Resistance Updates 53, 100721, 2020 | 73 | 2020 |
| High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations F Ceccherini-Silberstein, F Gago, M Santoro, C Gori, V Svicher, ... Journal of virology 79 (16), 10718-10729, 2005 | 65 | 2005 |
| Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 A Perfetti, S Greco, R Cardani, B Fossati, G Cuomo, R Valaperta, ... Scientific reports 6 (1), 1-10, 2016 | 54 | 2016 |
| Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy G Zehender, E Ebranati, A Lai, MM Santoro, C Alteri, M Giuliani, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 156-160, 2010 | 54 | 2010 |
| Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon J Fokam, R Salpini, MM Santoro, V Cento, CF Perno, V Colizzi, ... The Pediatric infectious disease journal 30 (12), 1062-1068, 2011 | 52 | 2011 |
| Impact of pre-therapy viral load on virological response to modern first-line HAART MM Santoro, D Armenia, C Alteri, P Flandre, A Calcagno, M Santoro, ... Antiviral therapy 18 (7), 867-876, 2013 | 48 | 2013 |
| Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens V Svicher, C Alteri, A Artese, F Forbici, MM Santoro, D Schols, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (3), 336-344, 2010 | 46 | 2010 |
| Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ... Journal of the International AIDS Society 22 (1), e25227, 2019 | 45 | 2019 |
| The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries M Salemi, MM Goodenow, S Montieri, T de Oliveira, MM Santoro, ... AIDS research and human retroviruses 24 (6), 771-779, 2008 | 45 | 2008 |
| Characterization of drug resistance mutations in naïve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon L Ceccarelli, R Salpini, S Moudourou, V Cento, MM Santoro, J Fokam, ... Journal of medical virology 84 (5), 721-727, 2012 | 43 | 2012 |
| Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon J Fokam, R Salpini, MM Santoro, V Cento, R D’Arrigo, C Gori, CF Perno, ... Archives of virology 156, 1235-1243, 2011 | 41 | 2011 |
| Specific Enfuvirtide-Associated Mutational Pathways in HIV-1 Gp41 Are Significantly Correlated With an Increase in CD4+ Cell Count, Despite Virological Failure S Valentina, S Aquaro, R D'Arrigo, A Artese, S Dimonte, S Alcaro, ... The Journal of infectious diseases 197 (10), 1408-1418, 2008 | 41 | 2008 |
Carlo Federico PernoUniversità di MilanoBestätigte E-Mail-Adresse bei uniroma2.it
